Management
Lesley Gouldie
B.Com., B.Acc., CPA, CA
President & CEO / Director
A seasoned professional with over 20 years of senior leadership experience spanning Fortune 500 to start-up companies, Ms. Gouldie brings a record of financial and strategic excellence in micro-electronics, biotechnology and content creation to helm Thornhill Medical.
Read more on LinkedIn.
Veso Tijanic
B.Sc, M.Sc.
Chief Operating Officer
With 25 years of experience in product development, including 15 medical technology-based products, Mr. Tijanic brings his deep sector-specific engineering knowledge to his role at Thornhill Medical, ensuring excellence, innovation, and rigour.
Read more on LinkedIn.
Joseph A. Fisher
MD, FRCP(C)
Chief Scientist / Director
As co-founder of Thornhill Medical and a world-renowned research scientist in the field of anesthesiology and cardiovascular intensive care, Dr. Fisher brings a passion for innovative product development, grounded in his original scientific work described in more than 100 peer-reviewed articles and over 40 patents, awarded and pending. He is currently a Staff Anaesthetist at the University Health Network, ensuring that clinical relevance and excellence is always at the forefront of his work.
Read more on LinkedIn.
Ludwik Fedorko
MD, PhD, FRCP(C)
Senior Scientist / Director
A published researcher with expertise in cardiovascular anesthesia, heart and lung transplantation and cardiovascular intensive care, Dr. Fedorko is an invaluable senior member of the scientific team at Thornhill Medical, contributing his specialised knowledge and expertise.
Wen Chen
BS, MS
Director
Mr. Chen is a Senior Vice President of Tigermed Co. Ltd., a publicly traded company located in China, dedicated to providing professional clinical development services to the pharmaceutical and medical device industries. Mr. Chen also represents Yonghua Capital, a leading private equity and venture capital investment firm from China. Mr. Chen received a Bachelor’s Degree in biochemistry from Purdue University, West Lafayette, IN and a Master’s Degree in immunology and oncology and business administration from Washington University in St. Louis and Durham University, respectively. He then worked at Amgen research before returning to work in the China biotechnology industry since 2000.
Read more on LinkedIn.
Chong Wang
BS, MS, PhD
Director
As the Yonghua Vice-General Manager, Mr. Wang has over eight years of experience in medical device R&D, engineering, and product management. He brings to Thornhill Medical his extensive knowledge of and expertise in healthcare-related investment.
Read more on LinkedIn.
Advisory Board
David Mikulis
MD, FRCR
Advisor
Dr. Mikulis is Professor and Co-Director of Medical Imaging Research in the Department of Medical Imaging at the University of Toronto and the University Health Network. He is also Director of the Radiology Residency Research Program and Director of the Functional Imaging Research Lab. Dr. Mikulis is one of the founding members of the American Society of Functional Neuroradiology (ASFNR), and currently serves on the ASFNR Executive Committee.
Seemant Chaturvedi
MD, FAHA, FAAN
Advisor
Dr. Chaturvedi is Professor of Neurology at Wayne State University School of Medicine and Director of the Wayne State/Detroit Medical Center Comprehensive Stroke Program. He has co-edited the books Transient Ischemic Attacks (2004) and Carotid Artery Stenosis: Current and Emerging Treatments (2005). He was chairman of the Carotid Endarterectomy Guidelines Committee of the American Academy of Neurology, the guidelines having been published in 2005. He is currently on the steering committee of several stroke prevention studies.
Colin Derdeyn
MD
Advisor
Dr. Derdeyn is Professor of Radiology, Neurology and Neurological Surgery at Washington University and Director of the Washington University/Barnes Jewish Hospital Stroke and Cerebrovascular Center. He is a Principal Investigator for the Stenting and Aggressive Medical Management for the Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) trial, an ongoing randomized trial of angioplasty and stenting for intracranial atherosclerotic disease. He directs the Washington University Specialized Program for Translational Research in Acute Stroke (SPOTRIAS) Center. Dr. Derdeyn also chairs the Data and Safety Monitoring Boards for two ongoing NIH-funded acute stroke clinical trials (MR Rescue and ICTus 2/3).
Steve Iscoe
PhD
Advisor
Dr. Iscoe, a collaborator of Dr. Fisher since 1994, was a founding shareholder and president of one of the companies that became Thornhill Medical. A retired Professor of Physiology at Queen’s University, his research focused primarily on control of the diaphragm, particularly how respiratory loads induce cardiorespiratory failure. An associated aspect was the development of a novel blood test for detecting skeletal muscle injury. His background as a respiratory physiologist contributed to the development of the company’s breathing circuits that maintain carbon dioxide levels independent of ventilation, and to their research and clinical applications.
Brendan Cunneen
CMC
Advisor
Mr. Cunneen is a Certified Management Consultant who has been addressing the needs of Canadian entrepreneurs for over 30 years. He has worked with the Business Development Bank of Canada as Vice President of Consulting Services, been COO/co-owner in a consulting practice acquired by Ernest & Young LLP, and is currently focused on strategic, high value mergers and acquisitions.
Corporate / Engineering:
210 Dundas St. W, Suite 200
Toronto, ON, Canada M5G 2E8
Research Lab:
Contact Us
Toll Free: 1-888-597-1325
T: +1 416-597-1325
F: +1 416-597-1330
E: info@thornhillmedical.com
Follow Us
